INS and B-cell chronic lymphocytic leukemia: Subject ID 5, diagnosed with chronic lymphocytic leukemia (CLL) (a consequence of prior mitoxantrone use for SPMS), exhibited an unexpected sharp rise in serum insulin (Figure S1).